Ignite Creation Date:
2024-05-06 @ 8:09 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02682511
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2016-02-08
Brief Title:
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis SSc or SSc-associated Pulmonary Arterial Hypertension
Sponsor:
Cumberland Pharmaceuticals
Organization:
Cumberland Pharmaceuticals
Organization Data
Organization:
Cumberland Pharmaceuticals
Class:
INDUSTRY
Study ID:
CPI-IFE-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cumberland Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None